Difference between revisions of "Team:UCL/Playingaround3"
(32 intermediate revisions by 2 users not shown) | |||
Line 3: | Line 3: | ||
− | |||
<link rel="stylesheet" type="text/css" href="//fonts.googleapis.com/css?family=Raleway"/> | <link rel="stylesheet" type="text/css" href="//fonts.googleapis.com/css?family=Raleway"/> | ||
Line 148: | Line 147: | ||
display: block; | display: block; | ||
} | } | ||
− | |||
− | |||
#twitbox {width: 30%; display: inline-block; padding-right: 30px; border-right: 1px solid #574B61; | #twitbox {width: 30%; display: inline-block; padding-right: 30px; border-right: 1px solid #574B61; | ||
} | } | ||
Line 192: | Line 189: | ||
padding-top: 20px; color: #FFFFFF; | padding-top: 20px; color: #FFFFFF; | ||
text-align: center; | text-align: center; | ||
− | position: relative; | + | position: relative; top: 20px; |
} | } | ||
Line 362: | Line 359: | ||
width: 80%; | width: 80%; | ||
margin: 0 auto; | margin: 0 auto; | ||
+ | |||
position: relative; | position: relative; | ||
vertical-align: middle; | vertical-align: middle; | ||
Line 376: | Line 374: | ||
− | #abstracttext p {line-height: 2; padding-left: 30px; padding-right: 30px; font-size: 15px; | + | #abstracttext p { line-height: 2; padding-left: 30px; padding-right: 30px; font-size: 15px; |
} | } | ||
Line 385: | Line 383: | ||
+ | } | ||
#abstract h2 {font-size: 20px;} | #abstract h2 {font-size: 20px;} | ||
Line 470: | Line 469: | ||
.menu-items li ul li a {color: #fff; font-size: 14px;} | .menu-items li ul li a {color: #fff; font-size: 14px;} | ||
− | + | .menu-items li ul li a:hover {color: #726082;} | |
.menu-items a {color: #473E4F; text-decoration: none; font-family: Raleway; | .menu-items a {color: #473E4F; text-decoration: none; font-family: Raleway; | ||
} | } | ||
Line 578: | Line 577: | ||
left: 3%; | left: 3%; | ||
background-position: 0 50%; | background-position: 0 50%; | ||
+ | z-index:100; | ||
} | } | ||
Line 587: | Line 587: | ||
.sssprev:hover, .sssnext:hover { | .sssprev:hover, .sssnext:hover { | ||
cursor: pointer; | cursor: pointer; | ||
+ | |||
} | } | ||
Line 596: | Line 597: | ||
box-sizing: border-box; | box-sizing: border-box; | ||
background: #fff; | background: #fff; | ||
− | height: | + | height: 380px; |
} | } | ||
Line 603: | Line 604: | ||
width: 60%; | width: 60%; | ||
margin: 0 auto; | margin: 0 auto; | ||
− | padding-top: 10%; height: | + | padding-top: 10%; height: 400px; |
} | } | ||
Line 671: | Line 672: | ||
<div id="logo"> | <div id="logo"> | ||
− | <img src="https://static.igem.org/mediawiki/2015/d/d4/UCL_mtg2.png" class="logophoto" style="margin-bottom:40px; margin-top:-35px" /> | + | <img src="https://static.igem.org/mediawiki/2015/d/d4/UCL_mtg2.png" class="logophoto" style="margin-bottom:40px; margin-top:-35px" alt="Mind the Gut" /> |
<div class="intro-buttons" id="box-links"> | <div class="intro-buttons" id="box-links"> | ||
<a data-scroll data-options='{ "easing": "linear" }' href="#intro1" class="buttonblack">Learn more</a> | <a data-scroll data-options='{ "easing": "linear" }' href="#intro1" class="buttonblack">Learn more</a> | ||
Line 705: | Line 706: | ||
</div> | </div> | ||
</div> | </div> | ||
+ | <div style="clear: both;"></div> | ||
Line 712: | Line 714: | ||
</div> | </div> | ||
+ | |||
Line 732: | Line 735: | ||
<div style="clear: both;"></div> | <div style="clear: both;"></div> | ||
− | + | ||
− | + | ||
− | + | ||
</div> | </div> |
Latest revision as of 15:52, 22 July 2015
Mind the Gut: Abstract
The gut–brain axis refers to the biochemical signalling taking place between the gastrointestinal tract and the nervous system, often involving intestinal microbiota, which have been shown to play an important role in healthy brain function. The current research suggests that gut microbes secrete neuroactive compounds – including neurotransmitters – that interact with the brain via two main mechanisms: the vagus nerve, connecting brain and digestive tract, and the immune system, which maintains its own means of communication with the brain.
In line with the ongoing research, UCL iGEM 2015 aims to develop synthetic probiotic strains that mimic the neuromodulatory strategies identified in gut microbes, with a focus on regulation of tryptophan pathway and signalling via serotonin. Additionally, in order to incorporate our neuromodulators into precise and safe therapeutic devices, we are developing a set of sensors capable of detecting mood-related physiological changes in the gut environment.
Available small molecule treatments are associated with both stigma and side effects. We believe that, besides aiding in better understanding of the communication between the gut microbiome and nervous system, our work will also lay a foundation for novel user-friendly treatments targeting a range of mental health disorders.